Antidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998-2000

British Journal of Psychiatry

Volumn 184, Issue JAN., 2004, Pages 41-47

  Cheeta, Survjit ^a   Schifano, Fabrizio ^a   Oyefeso, Adenekan ^a   Webb, Lucy ^a   Ghodse, A Hamid ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; AMOXAPINE; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; DOSULEPIN; FLUOXETINE; FLUVOXAMINE; IMIPRAMINE; ISOCARBOXAZID; LOFEPRAMINE; MAPROTILINE; MIANSERIN; MIRTAZAPINE; MONOAMINE OXIDASE INHIBITOR; NEFAZODONE; NORTRIPTYLINE; PAROXETINE; PHENELZINE; PROTRIPTYLINE; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRANYLCYPROMINE; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; UNINDEXED DRUG; VENLAFAXINE;

ARTICLE; COST BENEFIT ANALYSIS; DEPRESSION; DRUG COST; DRUG DEPENDENCE; DRUG FATALITY; DRUG MISUSE; HEART ARRHYTHMIA; HUMAN; MORTALITY; POPULATION RESEARCH; PRESCRIPTION; SIDE EFFECT; SUICIDE; UNITED KINGDOM;

ANTIDEPRESSIVE AGENTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; CAUSE OF DEATH; DRUG INTERACTIONS; ENGLAND; HUMANS; OVERDOSE; SEROTONIN UPTAKE INHIBITORS; SUBSTANCE-RELATED DISORDERS; SUICIDE; WALES;

EID: 0345742559     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.184.1.41     Document Type: Article

References (28)

1. Ables, A. Z. & Baughman, O. L. (2003) Antidepressants: update on new agents and indications. American Family Physician, 67, 547-554.
2. Bland, J. M. (1990) CLINSTAT Users' Guide. London: St George's Hospital Medical School.
3. Blythe, D. & Hackett, L. P. (1999) Cardiovascular and neurological toxicity of venlafaxine. Human and Experimental Toxicology, 18, 309-313.
4. Buckley, N. A. & McManus, P. R. (2002) Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data. BMJ, 325, 1332-1333.
5. Crewe, H. K., Lennard, M. S., Tucker, G. T., et al (1992) The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes. British Journal of Clinical Pharmacology, 34, 262-265.
6. Darcy, P., Kelly, J. P., Leonard, B. E., et al (2002) The effect of lofepramine and other related agents on the motility of Tetrahymena pyriformis. Toxicology Letters, 128, 207-214.
7. Donoghue, J. M. & Tylee, A. (1996) The treatment of depression: prescribing patterns of antidepressants in primary care in the UK. British Journal of Psychiatry, 168, 164-168.
8. Donoghue, J. M. & Taytor, D. M. (2000) Suboptimal use of antidepressants in the treatment of depression. CNS Drugs, 13, 365-383.
9. Drent, M., Singh, S., Gorgels, A. P., et al (2003) Drug-induced pneumonitis and heart failure simultaneously associated with venlafaxine. American Journal of Respiratory and Critical Care Medicine, 167, 958-961.
10. Dunn, R. L., Donoghue, J. M., Ozminkowski, R. J., et al (1999) Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines. Journal of Psychopharmacology, 13, 136-143.
11. Fava, M. (2001) Augmentation and combination strategies in treatment-resistant depression. Journal of Clinical Psychiatry, 62 (suppl. 18), 4-11.
12. Freeman, J. W., Mundy, G. R., Beattie, R. R., et al (1969) Cardiac abnormalities in poisoning with tricyclic antidepressants. BMJ, 2, 610-611.
13. Furukawa, T. A., McGuire, H. & Barbui, C. (2002) Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review. BMJ, 325, 991-999.
14. Ghodse, H., Oyefeso, A., Webb, L., et al (2002) Drug-related Deaths as Reported by Coroners in England and Wales, January-June 2001 (np-SAD Surveillance Report no. 8). London: St Georges Hospital Medical School.
15. Henry, J. A., Alexander, C. A. & Sener, E. K. (1995) Relative mortality from overdose of antidepressants. BMJ, 310, 221-224.
16. Khalifa, M., Daleau, P. & Turgeon, J. (1999) Mechanism of sodium channel block by venlafaxine in guinea pig ventricular myocytes. Journal of Pharmacology and Experimental Therapeutics, 291, 280-284.
17. Ma, Y. & Henry, J. A. (2001) The antidotal effect of alpha(1)-acid glycoprotein on amitriptyline toxicity in cardiac myocytes. Toxicology, 169, 133-144.
18. Marshall, J. B. & Forker, A. D. (1982) Cardiovascular effects of tricyclic antidepressant drugs: therapeutic usage, overdose, and management of complications. American Heart Journal, 103, 401-414.
19. McCarthy, M. (1993) Depression treatment guidelines (letter). Lancet, 341, 1087.
20. Mlddleton, N., Gunnell, D., Whitley, E., et al (2001) Secular trends in antidepressant prescribing in the UK, 1975-1998. Journal of Public Health Medicine, 23, 262-267.
21. Oyefeso, A., Ghodse, H., Clancy, C., et al (1999) Suicide among drug addicts in the UK. British Journal of Psychiatry, 175, 277-282.
22. Reznik, I., Rosen, Y. & Rosen, B. (1999) An acute ischaemic event associated with the use of venlafaxine: a case report and proposed pathophysiological mechanisms. Journal of Psychopharmacology, 13, 193-195.
23. Richelson, E. (1997) Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs. Mayo Clinic Proceedings, 72, 835-847.
24. Sanchez, C. & Hyttel, J. (1999) Comparison of the effects of antidepressants and their metabolites on reuptake of biogenic amines and on receptor binding. Cellular and Molecular Neurobiology, 19, 467-489.
25. Shah, R., Uren, Z., Baker, A., et al (2001) Deaths from antidepressants in England and Wales 1993-1997: analysis of a new national database. Psychological Medicine, 31, 1203-1210.
26. Thompson, C. & Thompson, C. M. (1989) The prescribing of antidepressants in general practice: II. A placebo controlled trial of low dose dothiepin. Human Psychopharmacology, 4, 191-204.
27. Vaughan, D. A. (1988) Interaction of fluoxetine with tricyclic antidepressants. American Journal of Psychiatry, 145, 1478.
28. Witchel, H. J., Hancox, J. C. & Nutt, D. J. (2003) Psychotropic drugs, cardiac arrhythmia, and sudden death. Journal Clinical of Psychopharmacology, 23, 58-77.